MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-01-0037137
Upraj Pharmaceuticals Private Limited
Upraj Pharmaceuticals Private Limited - chemicals in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹32.38 Lakh
▲ 39% YoY
Net profit · FY 2025
₹37,975
Net margin 1.2%
EBITDA · FY 2025
₹69,238
EBITDA margin 2.1%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹27 Lakh
Secured borrowings
Company age
31 yrs
Est. 1995
Directors on board
3
As per MCA filings
About Upraj Pharmaceuticals Private Limited
Data last updated:
Upraj Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 15 June 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U85195RJ1995PTC010217. Its GSTIN is 09AAACU4546J2Z1 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Shivam Agarwal and Vinita Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 607 Vidhyadhar Ka Rasta Shree Ram Bhawan, Jaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.38 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹37,975 (net margin 1.2%) and EBITDA of ₹69,238 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹27 Lakh on record.
Upraj Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0037137). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85195RJ1995PTC010217
Registration Number 010217
Incorporation Date 15 June 1995
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0037137
Recognitions & Rankings of Upraj Pharmaceuticals
Contact details
Upraj Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address607 Vidhyadhar Ka Rasta Shree Ram Bhawan, Jaipur, Rajasthan, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Upraj Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Upraj Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Upraj Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Upraj Pharmaceuticals Private Limited, buy the company report.
Financials of Upraj Pharmaceuticals Private Limited
FY 2025 filings availableUpraj Pharmaceuticals Private Limited reported revenue of ₹32.38 Lakh (up 39% YoY) for FY 2025.
Revenue · FY 2025
₹32.38 Lakh ▲ 39%
Net profit · FY 2025
₹37,975 margin 1.2%
EBITDA · FY 2025
₹69,238 margin 2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 18%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 4%
5 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 39% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69,238 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37,975 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Upraj Pharmaceuticals Private Limited, buy the company report.
Board of directors of Upraj Pharmaceuticals Private Limited
Upraj Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivam Agarwal | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Vinita Rani Also directs: D Square Group LLP | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Bal Kishan Agarwal | Director | 15 Jun 1995 | 31 Years 5 Months | Current |
Auditor
Upraj Pharmaceuticals Private Limited is audited by M.K. MANGAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.K. MANGAL & ASSOCIATES | FY 2017 | 003192C |
Shareholding
The shareholding of Upraj Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Upraj Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 May 1998 | 90068285 | State Bank of India | ₹10 Lakh | Open | |
| 19 May 1998 | 90070224 | State Bank of India | ₹2 Lakh | Open | |
| 15 Oct 1997 | 90070120 | State Bank of India | ₹15 Lakh | Open |
To see the full charge records of Upraj Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Upraj Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Upraj Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Upraj Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACU4546J2Z1 | Uttar Pradesh | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of Upraj Pharmaceuticals Private Limited, buy the company report.
Recent activity
Upraj Pharmaceuticals Private Limited has 8 board changes on record since 1995: 3 appointments and 5 cessations. The latest: Shivam Agarwal ceased to be Additional Director on 30 Nov 2021.
AGM
Upraj Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Upraj Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Shivam Agarwal ceased to be Additional Director.
Ceased
Vinita Rani ceased to be Additional Director.
Ceased
Suman Agarwal ceased to be Director.
Appointed
Shivam Agarwal was appointed as Director.
Appointed
Vinita Rani was appointed as Director.
Ceased
Nikhil Sharma ceased to be Director.
Ceased
Rajeev Goyal ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 10.00 Lakh registered on 19 May 1998 with Charge ID 90068285 was modified on 28 Mar 2000.
Charges
A charge with State Bank Of India amounted to Rs. 2.00 Lakh with Charge ID 90070224 was registered on 19 May 1998.
Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 90068285 was registered on 19 May 1998.
3 earlier events are in the company report.
Frequently asked questions
Upraj Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in chemical products, within the chemicals industry. It was incorporated on 15 June 1995 (31+ years old) and is registered under CIN U85195RJ1995PTC010217.
Upraj Pharmaceuticals has 3 current directors:
- Shivam Agarwal - Director
- Vinita Rani - Director
- Bal Kishan Agarwal - Director
The latest financial statements of Upraj Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Upraj Pharmaceuticals is 09AAACU4546J2Z1, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Upraj Pharmaceuticals is U85195RJ1995PTC010217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Upraj Pharmaceuticals was incorporated on 15 June 1995, making it 31+ years old. It is registered with the Registrar of Companies, Jaipur.
Shivam Agarwal ceased to be Additional Director on 30 Nov 2021. Vinita Rani ceased to be Additional Director on 30 Nov 2021. Suman Agarwal ceased to be Director on 28 Sep 2021. Upraj Pharmaceuticals has 8 board changes on record in total.
Yes, Upraj Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0037137).
The registered office of Upraj Pharmaceuticals is at 607 Vidhyadhar Ka Rasta Shree Ram Bhawan, Jaipur, Rajasthan, India.
Upraj Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages